Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus
✍ Scribed by Nathalie Costedoat-Chalumeau; Zahir Amoura; Jean-Sébastien Hulot; Hala Abou Hammoud; Guy Aymard; Patrice Cacoub; Camille Francès; Bertrand Wechsler; Du Le Thi Huong; Pascale Ghillani; Lucile Musset; Philippe Lechat; Jean-Charles Piette
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 164 KB
- Volume
- 54
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective Patients with systemic lupus erythematosus (SLE) are significantly more likely to experience a myocardial infarction or a stroke than age‐matched controls. We compared the prevalence of conventional and lupus‐specific risk factors in patients with SLE just before a cardiov
## Abstract ## Objective To examine the prevalence of and risk factors for low bone mineral density (BMD) and vertebral fractures in patients with systemic lupus erythematosus (SLE). ## Methods We studied 107 SLE patients. Demographic and clinical data were collected, and radiographs of the thor
Values are the number (percentage) of patients unless otherwise indicated. SLE ϭ systemic lupus erythematosus; PAD ϭ persistently active disease.
## Abstract ## Objective To clarify whether age at the time of the initial administration of corticosteroids is a risk factor for corticosteroid‐associated osteonecrosis in children with systemic lupus erythematosus (SLE), using magnetic resonance imaging (MRI). ## Methods From 1986 to 2007, MRI